Evidence map›Paper›PMID 22407517›Full record

ArticleJournal of muscle research and cell motility2012

Impact of the carbazole derivative wiskostatin on mechanical stability and dynamics of motile cells.

Eva K B Pfannes, Matthias Theves, Christian Wegner, Carsten Beta

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of muscle research and cell motility, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. 5,8-Dimethyl-9Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Eva K B PfannesBiological Physics, Institute of Physics and Astronomy, University of Potsdam, Potsdam, Germany.
Matthias Theves
Christian Wegner
Carsten Beta
University of Potsdam · DECzech Academy of Sciences, Institute of Physics · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many essential functions in eukaryotic cells like phagocytosis, division, and motility rely on the dynamical properties of the actin cytoskeleton. A central player in the actin system is the Arp2/3 complex. Its activity is controlled by members of the WASP (Wiskott-Aldrich syndrome protein) family. In this work, we investigated the effect of the carbazole derivative wiskostatin, a recently identified N-WASP inhibitor, on actin-driven processes in motile cells of the social ameba Dictyostelium discoideum. Drug-treated cells exhibited an altered morphology and strongly reduced pseudopod formation. However, TIRF microscopy images revealed that the overall cortical network structure remained intact. We probed the mechanical stability of wiskostatin-treated cells using a microfluidic device. While the total amount of F-actin in the cells remained constant, their stiffness was strongly reduced. Furthermore, wiskostatin treatment enhanced the resistance to fluid shear stress, while spontaneous motility as well as chemotactic motion in gradients of cAMP were reduced. Our results suggest that wiskostatin affects the mechanical integrity of the actin cortex so that its rigidity is reduced and actin-driven force generation is impaired.

Indexed as

ChemotaxisActin CytoskeletonActinsBiomechanical PhenomenaCarbazolesCell AdhesionDictyosteliumMicrofluidic Analytical TechniquesPropanolaminesProtozoan ProteinsPseudopodiaStress, PhysiologicalWiskott-Aldrich Syndrome Protein, NeuronalActinsCarbazolesPropanolaminesProtozoan ProteinswiskostatinWiskott-Aldrich Syndrome Protein, Neuronal

Identifiers

PMID22407517
OpenAlexW1985020613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.